Roberto Da Cas
Impact in
-
- Antibiotic Use and Resistance
- Toxicology top 5%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
-
- Antibiotic Use and Resistance 8
-
- SARS-CoV-2 and COVID-19 Research 7
- Co-authors
- Francesca Menniti‐Ippolito (18 shared papers)Roberto Raschetti (11 shared papers)Giuseppe Traversa (18 shared papers)Francesco Trotta (18 shared papers)Stefania Spila Alegiani (18 shared papers)Giuseppe Traversa (8 shared papers)Luca Lorenzoni (3 shared papers)Gabriela Mazzanti (2 shared papers)
- Journals
- PLoS ONE (5 papers)BMJ Open (4 papers)Neurological Sciences (4 papers)British Journal of Clinical Pharmacology (3 papers)European Journal of Clinical Pharmacology (3 papers)
- Partner nations
- ItalyArmeniaUnited States
In The Last Decade
Roberto Da Cas
82 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 108
- Applied Microbiology and Biotechnology 52
- Toxicology 51
- Infectious Diseases 209
- Pharmacology 167
- Geriatrics and Gerontology 24
Countries citing papers authored by Roberto Da Cas
This map shows the geographic impact of Roberto Da Cas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Da Cas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Da Cas more than expected).
Fields of papers citing papers by Roberto Da Cas
This network shows the impact of papers produced by Roberto Da Cas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Da Cas. The network helps show where Roberto Da Cas may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Da Cas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 78 | |
| 2 | 2017 | 73 | |
| 3 | 2000 | 66 | |
| 4 | 2021 | 53 | |
| 5 | 2020 | 44 | |
| 6 | 2009 | 42 | |
| 7 | 2014 | 38 | |
| 8 | 1999 | 36 | |
| 9 | 2022 | 36 | |
| 10 | 2011 | 34 | |
| 11 | 2012 | 33 | |
| 12 | 1995 | 32 | |
| 13 | 2020 | 30 | |
| 14 | 2013 | 29 | |
| 15 | 1998 | 29 | |
| 16 | 2016 | 29 | |
| 17 | 2016 | 26 | |
| 18 | 1998 | 26 | |
| 19 | 2017 | 24 | |
| 20 | 2014 | 23 |
About Roberto Da Cas
Roberto Da Cas is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Pharmacology, Endocrinology, Diabetes and Metabolism and Epidemiology, having authored 89 papers that have together received 1.3k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Pharmaceutical Economics and Policy (4 papers), Pharmaceutical studies and practices (3 papers), Schizophrenia research and treatment (3 papers), Pregnancy and Medication Impact (3 papers), Thyroid Disorders and Treatments (3 papers) and Drug-Induced Adverse Reactions (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (52 citations), Toxicology (51 citations), Infectious Diseases (209 citations), Pharmacology (167 citations) and Geriatrics and Gerontology (24 citations). Roberto Da Cas has collaborated with scholars based in Italy, Armenia and United States. Frequent co-authors include Francesca Menniti‐Ippolito, Roberto Raschetti, Giuseppe Traversa, Francesco Trotta, Stefania Spila Alegiani, Giuseppe Traversa, Luca Lorenzoni, Gabriela Mazzanti, Emanuel Raschi and Paola Angela Moro. Their work appears in journals such as PLoS ONE, BMJ Open, Neurological Sciences, British Journal of Clinical Pharmacology and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.